Latest return on equity
Dianthus Therapeutics Return on equity
Dianthus Therapeutics (DNTH) return on equity with its verified observation dat…
Direct answer
Dianthus Therapeutics's return on equity is -26.06%.
The verified market snapshot reports -26.06%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 15, 2026.
Get free Dianthus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -26.06%
Explore related company data
View Dianthus Therapeutics's market capitalizationView Dianthus Therapeutics's price-to-book ratioView Dianthus Therapeutics's 52-week price rangeView Dianthus Therapeutics's revenue growthView Dianthus Therapeutics's profit marginView Dianthus Therapeutics's debt-to-equity ratioView all Dianthus Therapeutics key metricsReturn to Dianthus Therapeutics profile